A recent study identifies critical hematological predictors for TAVI mortality in males, offering new insights into how sex influences long-term survival after heart valve procedures. Transcatheter aortic valve implantation (TAVI) has revolutionized the treatment of aortic stenosis, particularly for elderly patients. However, clinicians often face challenges in predicting long-term outcomes due to the complex interplay of comorbidities and physiological differences between sexes.

Researchers retrospectively evaluated 609 patients who underwent TAVI at Verona University Hospital. The study population had a median age of 83 years, with a nearly even split between sexes. While preoperative anemia was prevalent in over half the cohort, its impact on mortality varied significantly when stratified by sex. These findings emphasize the necessity of gender-sensitive risk assessment in cardiac care.

Red Blood Cell Distribution Width and TAVI Mortality in Males

The study highlights that red blood cell distribution width (RDW) is a potent predictor of TAVI mortality in males but not in females. Specifically, males with an RDW exceeding 15% faced a significantly higher risk of death within two years. In contrast, this hematological marker did not show the same predictive value for female patients. This discrepancy suggests that RDW might reflect different underlying pathological processes, such as chronic inflammation or nutritional deficiencies, which may affect sexes differently.

Interestingly, females in the study were less likely to be anemic at baseline compared to males. Despite this, they experienced more vascular complications and required blood transfusions more frequently within 30 days of the procedure. However, these periprocedural transfusions only correlated with increased 2-year mortality in the male subgroup. This suggests that while females are more prone to procedural bleeding, their long-term survival may be more resilient to these events compared to their male counterparts.

Clinical Implications for Practice

For clinicians in India, where the burden of anemia is high and TAVI is becoming more accessible, these results are particularly relevant. Monitoring RDW provides an inexpensive and readily available tool for risk stratification. Furthermore, the data suggests that male patients requiring transfusions may need more intensive post-procedural monitoring. Recognizing these sex-related differences allows for more personalized follow-up care and better communication of risks to patients and their families.

FAQ

Why does RDW predict mortality differently in males and females?

Physiological differences in hemoglobin levels and inflammatory responses may play a role. In males, a high RDW often reflects a more severe state of chronic illness or systemic stress, which more directly impacts long-term survival after major cardiac interventions.

Are blood transfusions always a risk factor for TAVI outcomes?

While transfusions are often linked to complications, this study found they were specifically associated with 2-year mortality in males. Females required more transfusions due to higher vascular complication rates, but this did not significantly diminish their 2-year survival probability.

Is preoperative anemia common in TAVI patients?

Yes, preoperative anemia was found in 55% of the study population. It is a frequent finding in the elderly TAVI cohort and serves as a broad indicator of frailty and increased procedural risk.

Disclaimer: This content is for informational and educational purposes only. It is not intended as medical advice or a substitute for professional clinical judgment. Refer to the latest local and national guidelines for clinical practice.

References

Vianello A et al. Red blood cell distribution width and blood transfusions are associated with 2-year mortality after transcatheter aortic valve implantation in males but not in females: sex-related differences in hematological predictors. Intern Emerg Med. 2026 Feb 22. doi: 10.1007/s11739-026-04267-4. PMID: 41723797.

Chandrasekhar J et al. Sex-Based Differences in Outcomes With Transcatheter Aortic Valve Therapy: TVT Registry. J Am Coll Cardiol. 2016;68(25):2733-2744. doi:10.1016/j.jacc.2016.10.041.